Results 81 to 90 of about 9,067 (180)

Analysis of Candida auris fungemia at a single facility in Kenya

open access: yesInternational Journal of Infectious Diseases, 2019
Objectives: Candida auris emerged as a human pathogen in 2009 and has subsequently been identified around the world as a cause of invasive candidiasis.
Rodney D. Adam   +8 more
doaj   +1 more source

Candida auris in a tertiary healthcare setting in south India: A case series [PDF]

open access: yesCurrent Medical Mycology
Candida species can produce a variety of clinical manifestations, and several non-albicans species of Candida, including Candida auris, have been linked to the rise of invasive fungal infections with high rates of treatment failure.
Asem Ashraf, Rohan Pinto, Vimal Karnaker
doaj   +1 more source

Standardisation of a Semi-nested PCR for Early Identification of Candida auris: A Cross-sectional Study from Southern India [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Candida auris has drawn more clinical attention due to its multidrug resistance. More than 90% of C. auris isolates are known to be resistant to all the antifungal drugs. Conventionally, the identification of C. auris has not been described
K Vichitra   +3 more
doaj   +1 more source

A Review of Candida auris

open access: yesQuality in Sport
Background. Candida auris is an emerging, multidrug-resistant fungal pathogen ofsignificant public health concern. Noted for its environmental persistence and hightransmissibility, it poses a substantial threat in healthcare settings, particularly inintensive care units, driving the need for specific infection control protocols. Aim.
Marta Krzyzaniak   +9 more
openaire   +1 more source

The Role of Drug Resistance in Candida Inflammation and Fitness

open access: yesMicroorganisms
Drug resistance in Candida may result in either a fitness cost or a fitness advantage. Candida auris, whose intrinsic drug resistance remains unclear, has emerged as a significant human pathogen. We aimed to investigate whether Candida fitness, including
Gabriella Piatti   +4 more
doaj   +1 more source

FIRST CASES IN BULGARIA WITH PROVEN CANDIDA AURIS IN IMMUNOCOMPROMISED PATIENTS

open access: yesProblems of Infectious and Parasitic Diseases
Candida auris is a fungus with pathogenic potential, first isolated in 2009 in Japan. Since then, sporadic cases have been reported, which have increased significantly in recent years.
Lyubomira Boyanova   +2 more
doaj   +1 more source

mGem: Fungal adhesins in Candidozyma auris confer unique fitness for skin colonization

open access: yesmBio
Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant fungal pathogen that causes life-threatening infections in humans. C. auris is distinct from other Candida species and exhibits exceptional capacity for skin colonization ...
Abishek Balakumar, Shankar Thangamani
doaj   +1 more source

Relationships Between Candida auris and the Rest of the Candida World—Analysis of Dual-Species Biofilms and Infections

open access: yesPathogens
In this study, we investigated the interactions between Candida auris and C. albicans, C. tropicalis, C. glabrata, and C. krusei in mixed infections. Initially, these interactions were studied qualitatively and quantitatively in dual-species biofilms ...
Monika Janeczko, Tomasz Skrzypek
doaj   +1 more source

Candida auris in Dutch hospitals: are we ready for it?

open access: yesJournal of Hospital Infection
Candida auris can cause nosocomial outbreaks and provides challenges concerning diagnosis, treatment, eradication and infection prevention. There are no Dutch standards or guidelines for C. auris, and current hospital practices are unknown. Therefore, we assessed whether Dutch hospitals are prepared for C.
Dix, L M L   +3 more
openaire   +6 more sources

Candida auris

open access: yes, 2019
Candida auris (C. auris) er en gjærsopp som kan forårsake alvorlige infeksjoner hos mennesker. Infeksjoner med Candida auris forekommer i hovedsak i helseinstitusjoner og rammer som regel alvorlig syke pasienter. I tillegg er behandling vanskelig fordi soppen ofte er resistent/motstandsdyktig mot de vanligste medikamentene som brukes ved Candida ...
openaire   +1 more source

Home - About - Disclaimer - Privacy